Effect of tiron and its combination with nutritional supplements against vanadium intoxication in female albino rats.
In the present study an attempt has been made to evaluate the effect of Tiron along with Zinc, Selenium and Vitamin E against vanadium intoxication in female albino rats. Toxicant caused significant increase in the activities of serum transaminases, serum alkaline phosphatase and lactate dehydrogenase. Significant decrease was observed in blood sugar, serum albumin and triglyceride levels whereas serum proteins, cholesterol and urea levels increased significantly during toxicity (p </= 0.001). Hepatic lipid peroxidation increased significantly, whereas significant depletion was observed in reduced glutathione after vanadium administration. The activity of glucose-6-phosphatase in the liver was also inhibited significantly after vanadium administration. A significant rise was observed in glycogen content of liver and kidney after toxicant exposure. Activities of alkaline phosphatase, adenosine triphosphatase and succinic dehydrogenase were inhibited significantly on the contrary activity of acid phosphatase elevated in kidney. Histopathological examination of the liver and kidney using light and ultramicroscopic study also substantiated the above findings. It was found that therapy with Tiron was effective but significant recovery in all the parameters was found with Tiron + Se followed by Tiron+ VitE and Tiron +Zn.
Shrivastava
Sadhana
S
Jadon
Anjana
A
Shukla
Sangeeta
S
D014013:1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D002614:Chelating Agents / Q000494:pharmacology*; D019587:Dietary Supplements; D004359:Drug Therapy, Combination; D004798:Enzymes / Q000097:blood; D005260:Female; D005978:Glutathione / Q000097:blood; D007004:Hypoglycemic Agents / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D011041:Poisoning / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012643:Selenium / Q000008:administration & dosage; D017968:Vanadium Compounds / Q000633:toxicity*; D014810:Vitamin E / Q000032:analysis; D015032:Zinc / Q000008:administration & dosage
D000975:Antioxidants; D002614:Chelating Agents; D004798:Enzymes; D007004:Hypoglycemic Agents; D017968:Vanadium Compounds; D014810:Vitamin E; D014013:1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; C034028:vanadyl sulfate; D005978:Glutathione; D012643:Selenium; D015032:Zinc